These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35911520)

  • 21. Lipoprotein lipase mass and activity in post-heparin plasma from subjects with intra-abdominal visceral fat accumulation.
    Kobayashi J; Tashiro J; Murano S; Morisaki N; Saito Y
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):515-20. PubMed ID: 9640420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the triacylglycerol hydrolase activity of human post-heparin plasma lipoprotein lipase and hepatic triacylglycerol lipase. A monolayer study.
    Jackson RL; Ponce E; McLean LR; Demel RA
    Biochemistry; 1986 Mar; 25(5):1166-70. PubMed ID: 3964663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WAT apoC-I secretion: role in delayed chylomicron clearance in vivo and ex vivo in WAT in obese subjects.
    Cyr Y; Wassef H; Bissonnette S; Lamantia V; Davignon J; Faraj M
    J Lipid Res; 2016 Jun; 57(6):1074-85. PubMed ID: 27040450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of protein structure-function in vivo. Adenovirus-mediated transfer of lipase lid mutants in hepatic lipase-deficient mice.
    Kobayashi J; Applebaum-Bowden D; Dugi KA; Brown DR; Kashyap VS; Parrott C; Duarte C; Maeda N; Santamarina-Fojo S
    J Biol Chem; 1996 Oct; 271(42):26296-301. PubMed ID: 8824281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E-knockout mice.
    Amar MJ; Sakurai T; Sakurai-Ikuta A; Sviridov D; Freeman L; Ahsan L; Remaley AT
    J Pharmacol Exp Ther; 2015 Feb; 352(2):227-35. PubMed ID: 25395590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiopoietin-like 3 inhibition of endothelial lipase is not modulated by angiopoietin-like 8.
    Sylvers-Davie KL; Segura-Roman A; Salvi AM; Schache KJ; Davies BSJ
    J Lipid Res; 2021; 62():100112. PubMed ID: 34461133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
    J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(6):e99721. PubMed ID: 24886863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ex vivo measurement of lipoprotein lipase-dependent very low density lipoprotein (VLDL)-triglyceride hydrolysis in human VLDL: an alternative to the postheparin assay of lipoprotein lipase activity?
    Pruneta V; Autran D; Ponsin G; Marcais C; Duvillard L; Verges B; Berthezene F; Moulin P
    J Clin Endocrinol Metab; 2001 Feb; 86(2):797-803. PubMed ID: 11158049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein C-II39-62 activates lipoprotein lipase by direct lipid-independent binding.
    MacPhee CE; Hatters DM; Sawyer WH; Howlett GJ
    Biochemistry; 2000 Mar; 39(12):3433-40. PubMed ID: 10727238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III.
    McConathy WJ; Gesquiere JC; Bass H; Tartar A; Fruchart JC; Wang CS
    J Lipid Res; 1992 Jul; 33(7):995-1003. PubMed ID: 1431591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
    Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
    PLoS One; 2014; 9(5):e96482. PubMed ID: 24788417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human lipoprotein lipase: the loop covering the catalytic site is essential for interaction with lipid substrates.
    Dugi KA; Dichek HL; Talley GD; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1992 Dec; 267(35):25086-91. PubMed ID: 1460010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III.
    Sun HY; Lin CC; Lee JC; Wang SW; Cheng PN; Wu IC; Chang TT; Lai MD; Shieh DB; Young KC
    Gut; 2013 Aug; 62(8):1193-203. PubMed ID: 22689516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma.
    Nakajima K; Machida T; Imamura S; Kawase D; Miyashita K; Fukamachi I; Maeda M; Muraba Y; Koga T; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Dec; 487():54-59. PubMed ID: 30218657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor.
    Mukherjee M; Kakkar VV
    Thromb Haemost; 1999 Dec; 82(6):1648-51. PubMed ID: 10613650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic Variants of Lipoprotein Lipase and Regulatory Factors Associated with Alzheimer's Disease Risk.
    D Bruce K; Tang M; Reigan P; H Eckel R
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage.
    Gunn KH; Roberts BS; Wang F; Strauss JD; Borgnia MJ; Egelman EH; Neher SB
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10254-10264. PubMed ID: 32332168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
    Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
    J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.